Helmsley Grant to UFDI to Study Immune Repertoire in T1D

Published: November 16th, 2018

Category: Feature

University of Florida and Kings College London have secured a $3.7 million grant funded by Adaptive Biotechnologies and the Leona M. and Harry B. Helmsley Charitable Trust to profile T cell receptor sequences in Type 1 Diabetes.

Congratulations to co-investigators Dr. Todd Brusko and Dr. Mark Peakman!